Vaccines
Scientists at University of Oxford, Department of Paediatrics target vaccines
Published in Vaccine Weekly, December 15th, 2010
2010 DEC 15 -- Current study results from the report, 'Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial,' have been published. "An investigational vaccine against serogroup B meningococcal (MenB) disease containing 3 main recombinant proteins (factor H-binding protein, Neisserial adhesion A, and Neisserial heparin-binding antigen) has been developed. We evaluated the immunogenicity and reactogenicity of a 3-dose course of this vaccine administered alone (recombinant MenB [rMenB]) or combined with the outer membrane vesicle (OMV) component of the vaccine used in New Zealand (rMenB+OMV),"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-12-15)
More Articles from Vaccine Weekly
- Pediatric Vaccines
Preterm infants may need a boost - Active Immunotherapy
Reports from Marmara University, Faculty of Medicine advance knowledge in active immunotherapy - Hepatitis
Reports from University of Cincinnati, Department of Pediatrics highlight recent research in hepatitis - Pediatric Vaccines
Research from Aga Khan University in the area of pediatric vaccines published - Pediatric Vaccines
Research from University of Santiago in pediatric vaccines provides new insights - Pediatric Vaccines
Study data from S.J. Moss et al provide new insights into pediatric vaccines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
